Predictive models for the risk and prognosis of bone metastasis in patients with newly-diagnosed esophageal cancer: A retrospective cohort study

被引:2
|
作者
Yuan, Bei [1 ]
Lu, Haojie [1 ]
Hu, Dong [1 ]
Xu, Kai [1 ]
Xiao, Songhua [1 ]
机构
[1] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Orthopaed, Beijing, Peoples R China
来源
FRONTIERS IN SURGERY | 2023年 / 9卷
关键词
bone metastasis; esophageal cancer; nomogram; overall survival; prognosis; AUTOPSY FINDINGS; 7TH EDITION; SURVIVAL; NOMOGRAM; CLASSIFICATION; CARCINOMA;
D O I
10.3389/fsurg.2022.1014781
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundEsophageal cancer (EC) is a common malignant tumor worldwide, and patients with both EC and bone metastasis (BM) have a poor prognosis. We aimed to determine the risk and prognostic factors for BM in patients with newly diagnosed EC and to conduct two nomograms to predict the probability of BM and overall survival after BM. MethodsData from patients with EC from 2010 to 2015 were reviewed in the Surveillance, Epidemiology, and End Results (SEER) database. We divided participants into training and validation cohorts using univariate and multivariate logistic regression analyses and Cox regression models to explore the risk and prognostic factors of BM, respectively. Moreover, two nomograms were developed for predicting the risk and prognosis of BM in patients with EC. Then we used receiver operating characteristic curves, decision curve analysis, and calibration curves to evaluate the nomogram models. The overall survival of patients with EC and BM was analyzed using the Kaplan-Meier method. ResultsA total of 10,730 patients with EC were involved, 735 of whom had BM at the time of diagnosis. Histologic type, sex, age, N stage, primary site, liver, lung, and brain metastases, and tumor differentiation grade were identified as independent BM risk factors. Histological type, chemotherapy, brain, liver, and lung metastases were identified as prognostic risk factors for patients with EC and BM. We developed diagnostic and prognostic nomograms according to the results. Receiver operating characteristic curves, calibration, and Kaplan-Meier curves, and decision curve analysis all indicated that both nomograms had great clinical predictive ability and good clinical application potential. ConclusionsTwo novel nomograms were constructed to predict the risk and prognosis of BM in patients with EC. These prediction models can effectively assist clinicians in clinical decision-making based on their good accuracy and reliability.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Retrospective analysis of risk factors for bone metastasis in newly diagnosed prostate cancer patients
    PENG, C.
    JUAN, C.
    MAO, W.
    JINGHE, Y.
    RENLI, T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (11) : 3832 - 3839
  • [2] Treatment of newly-diagnosed hypertensive patients in Italy: A retrospective cohort study in primary care
    Bustacchini, S
    Mazzaglia, G
    Sturkenboom, MC
    Ruffo, P
    Mantovani, LG
    Brignoli, O
    Caputi, AP
    VALUE IN HEALTH, 2004, 7 (06) : 703 - 703
  • [3] Risk factors of bone metastasis in patients with newly diagnosed prostate cancer
    Chaoying, L.
    Chao, M.
    Xiangrui, Y.
    Yingjian, H.
    Gang, Z.
    Yunhan, R.
    Yu, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (02) : 391 - 398
  • [4] Risk Factors and Prognosis of Extramedullary Disease in Newly-Diagnosed Multiple Myeloma Patients
    Gunes, Ebru K. I. L. I. C.
    Bulduk, Tuba
    Dumludag, Burak
    Zengin, Haydar
    Yildirim, Murat
    Comert, Melda
    Ayli, Meltem
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2024, 34 (04): : 175 - 183
  • [5] Risk Factors and Prognosis of Extramedullary Disease in Newly-Diagnosed Multiple Myeloma Patients
    Gunes, Ebru Kilic
    Bulduk, Tuba
    Dumludag, Burak
    Zengin, Haydar
    Yildirim, Murat
    Comert, Melda
    Ayli, Meltem
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S167 - S168
  • [6] A Nomogram for Predicting the Risk of Bone Metastasis in Newly Diagnosed Head and Neck Cancer Patients: A Real-World Data Retrospective Cohort Study From SEER Database
    Huang, Chao
    He, Jialin
    Ding, Zichuan
    Li, Hao
    Zhou, Zongke
    Shi, Xiaojun
    FRONTIERS IN GENETICS, 2022, 13
  • [7] Risk of stroke in patients with newly diagnosed multiple myeloma: a retrospective cohort study
    Lee, Gin-Yi
    Lee, Yu-Ting
    Yeh, Chiu-Mei
    Hsu, Pei
    Lin, Ting-Wei
    Gau, Jyh-Pyng
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Tzeng, Cheng-Hwai
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Liu, Yao-Chung
    Liu, Chia-Jen
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 726 - 733
  • [8] Predictive models based on machine learning for bone metastasis in patients with diagnosed colorectal cancer
    Li, Tianhao
    Huang, Honghong
    Zhang, Shuocun
    Zhang, Yongdan
    Jing, Haoren
    Sun, Tianwei
    Zhang, Xipeng
    Lu, Liangfu
    Zhang, Mingqing
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [9] Mean platelet volume at baseline and immune thrombocytopenia relapse in Chinese newly-diagnosed patients: a retrospective cohort study
    Chen, Chi
    Song, Jun
    Wang, Qing
    Wang, Lin-Hui
    Guo, Peng-Xiang
    HEMATOLOGY, 2018, 23 (09) : 646 - 652
  • [10] Risk factor analysis and predictive model construction for bone metastasis in newly diagnosed malignant tumor patients
    Hu, Chengru
    Wu, Jing
    Duan, Zhipei
    Qian, Jing
    Zhu, Jing
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (10): : 5890 - 5899